Research programme: viral and bacterial infections therapeutics - Starpharma

Drug Profile

Research programme: viral and bacterial infections therapeutics - Starpharma

Alternative Names: Angiogenesis inhibitor research programme - Starpharma Pooled Developments; Second-generation dendrimers research programme - Starpharma Pooled Developments; Topical microbicides research programme - Starpharma Pooled Developments

Latest Information Update: 29 Mar 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Biomolecular Research Institute
  • Developer Starpharma
  • Class Dendrimers
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections; Hepatitis B; Respiratory tract infections; Sexually transmitted infections; Viral infections

Most Recent Events

  • 06 Oct 2006 Preclinical trials in Hepatitis B in Australia (unspecified route)
  • 06 Oct 2006 Preclinical trials in Respiratory tract infections in Australia (unspecified route)
  • 31 May 2004 Preclinical trials in Venereal infections in Australia (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top